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ABSTRACT
Using linker-scanning mutagenesis we had previously identified four elements within the MMTV
LTR which are necessary for transcriptional stimulation by glucocorticoid hormones. Two of them
overlapped with regions to which the glucocorticoid receptor binds in vitro. The third element contained
a NF-I binding site, and the fourth the TATA box. Here we show that mutations that abolish in
vitro binding of NF-I had a negative effect also on the basal activity of the MMTV promoter of
LTR-containing plasmids stably integrated in Ltk- fibroblasts. The analysis of double mutants altered
in the NF-I plus either one of the receptor binding elements further demonstrated that the NF-I site
functionally cooperated with the proximal (-120) element, which alone was extremely inefficient
in stimulation. The stronger distal (- 181/-172) element was independent of NF-I and showed
functional cooperativity with the proximal hormone-binding element.
INTRODUCTION
Transcription from the proviral DNA of mouse mammary tumor virus (MMTV) is
controlled by steroid hormones (1,2) through their binding to receptor proteins and the
interaction of hormone-receptor complexes with regulatory DNA sequences, thereby
causing an increase of the number of active RNA polymerase II molecules on the MMTV
promoter (3). The hormone-responsive sequences are located in the long terminal repeat
(LTR) of the provirus (4,5,6,7), in a region of approximately 200 bp upstream of the
transcription start site (8,9,10). While steroids like progestins and androgens have recently
been shown to also affect MMTV transcription in mammary cells (11,12,13,14,15), it
is the response to glucocorticoids in cultured fibroblasts that has been studied in greatest
detail (16,17,18,19). In vitro binding of purified glucocorticoid receptor to MMTV DNA
has been demonstrated, showing several binding sites within the glucocorticoid regulatory
region (20,21,22).
Several reasons make MMTV a particularly suitable model system for studying
transcription regulation by glucocorticoid hormones. High stimulation factors (200-fold
and more; ref. 19) are observed after addition of dexamethasone, a synthetic glucocorticoid,
to cells containing the natural MMTV promoter plus the regulatory region. Stimulation
occurs over a low basal promoter activity which is independent of the presence of hormone
or of hormone-responsive sequences (8,9). These sequences are located relatively close
to the promoter and contain several regulatory elements which act in a cooperative fashion
to achieve an optimal level of transcription (18). In a previous study using linker-insertion
mutants (18) we have identified four distinct control elements for glucocorticoid regulation
(Fig. 1A). Two of them (a distal one, between -18I and -172, and a proximal one,
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Figure 1. Scheme of plasmids.
A. The MMTV LTR is joined to the coding region of the herpes virus TK gene via a Bam HI linker. The
wavy line denotes pBR322 sequences. Restriction sites are: E, Eco RI; Sa, Sal I; B, Bam HI; S, Sst I; P,
Pvu II. The position of the 142-nt Si-nuclease protected fragment is indicated. The GRE-containing segment
of the LTR is enlarged, the numbers being the distance in bp from the transcription initiation site. Previously
defined glucocorticoid regulatory elements (18) are boxed: those contained in receptor binding sites (distal
and proximal), the NF-I binding site, and the TATA box. B (distal) and C (proximal): sequence of regulatory
regions and mutants therein (coding strand). Below the wild-type sequence (7), two lines indicate the DNase
I footprints (on both strands) of purified glucocorticoid receptor (20). Triangles (open for protection, filled
for enhancement) point to residues involved in methylation protection experiments, and squares to residues
involved in methylation interference (22). In the sequence of linker scanning mutants (18), mutated nucleotides
are boxed, and hyphens indicate deletions.
around -120) overlapped with sequences that interact in vitro with purified receptor (Fig.
1B,C). The other two were more proximally located: One contained the TATA-box (23)
and its deletion resulted in both reduction of hormone response and generation of low levels
of RNA with heterogeneous start sites. The other overlapped with the binding site for
the so-called 'TGGCA-binding protein' (24,25,26,27), a functional equivalent of the
ubiquitous nuclear factor I (NF-I; 28,29), which was shown to increase the rate of initiation
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Figure 2. A,B. SI nuclease protection assay of RNA transcribed from the GRE deletion mutants including
or not the NF-I binding site, and from their derivatives containing the SV40 enhancer (E).
Stably transfected Ltk+ cells were treated (+) or not (-) with 1 uM dexamethasone for 16 hr, and the
cytoplasmic RNA was extracted. 20 jig of RNA were annealed to an excess of 5'-labeled, MMTV-LTR con-
taining Bam HI fragment (Fig. IA) and digested with SI nuclease. The 142-nt fragment protected by correctly
initiated RNA is indicated by an arrowhead. Numbers to the right give the size in nucleotides of marker DNA
fragments (lane M). A (bottom panel): slot-blot analysis with 2 /g of RNA hybridized to a ,B-actin probe.
Slot y contains yeast RNA as a control. C. Southern blot analysis of Bam HI-digested DNA from the same
transfected cells (lanes 2-6) shown in A and B, and from untransfected Ltk- cells (lane 1). The filter was
hybridized to a 32P-labeled LTR probe. Weak bands present in all lanes are due to MMTV copies endogenous
to L cells and constitute an internal standard for DNA amounts in each lane.
of adenovirus replication (28,30,31,32) via the recognition of binding sites in the viral
DNA (33,31,32,29). The fact that both TATA and NF-I elements map in a region that
by itself does not provide any hormone response (8,9) suggests that they act in concert
with receptor binding sites in the process of transcriptional stimulation by the hormone.
While the role of the TATA box in promoter activity is well established (23), it was unclear
from the previous studies (18,27) whether the NF-I binding site affected only the stimulation
of transcription or the basal level as well. Here we investigate the role of NF-I in hormone-
independent transcription, and its functional interactions with the other control elements.
MATERIALS AND METHODS
Plasmid construction, transfection and nucleic acids analysis.
Construction of the linker scanning mutants has been described previously (19). The
plasmids 193/78E and 193/57E contain the simian virus 40 (SV40) 72-bp repeat enhancer
(present as an Xho I fragment in the rabbit 3-globin-containing plasmid H514, provided
by W. Schaffner) inserted into their unique Sal I site (Fig. IA). Double mutants were
assembled by ligation of three gel-purified DNA fragments: 1) the 3.5-kb Eco RI/Bam
HI fragment containing pBR322 and thymidine kinase sequences (Fig. IA) as a vector;
2) a 1-kb Eco RI/Sst I fragment from the upstream mutant; 3) a 0.25-kb Sst I/Bam HI
fragment from the downstream mutant. After cloning in E. coli HB 101, recombinants
were recognized by the presence and location of the two synthetic Hind III restriction sites
that constitute the mutations. The sequence of the 123-bp spacer fragment of mouse DNA
has been determined (19). Stable and transient transfection assays by calcium phosphate
precipitation (34), isolation of nucleic acids, DNA and RNA blot analysis, and nuclease
SI mapping (35) were performed as described previously (18,19).
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Figure 3. DNase I footprinting analysis of NF-I on wild-type and mutated MMTV LTR DNA.
A 445-bp Sty I-Bam HI fragment from -306 to the 3' end of the LTR (3'-32P-end-labeled in the coding strand
at the Bam HI site of the linker at + 139) was incubated either with no extract (FREE) or with increasing
amounts of nuclear extracts from Ltk- cells, either untreated (L-) or treated for 16 h with I iM dexamethasone
(L+). After limited digestion with DNase I, the deproteinized DNAs were electrophoresed on a denaturing
6% polyacrylamide gel with radioactive size markers (M). Numbers on both sides of the autoradiogram denote
fragment lengths in nucleotides. Numbers at the bottom refer to positions with respect to the RNA start site,
as determined by sequencing of the probe.
DNase I footprinting
Ltk- cells were lysed with 0.5% Triton X-100 and nuclear extracts were prepared
according to ref. 36. DNase I protection experiments (37) were performed according to
ref. 38 using a DNA probe asymmetrically labeled with o932P-dGTP and Klenow DNA
polymerase. The probe was incubated for 15 min at 0 C with or without nuclear extract,
in the presence of 50 ytg/ml of poly (dl:dC).
RESULTS
NF-I contributes to the basal level of transcription from the MMTV promoter.
Previous data (18,27) demonstrated that the NF-I binding site in the MMTV LTR is required
for maximal transcriptional stimulation by glucocorticoid hormones. Results obtained with
deletion mutants of the proximal receptor binding site including or not the NF-I element
(19) suggested that the latter may be important for the basal level of transcription as well.
To examine this possibility, deletion mutants were constructed in which both glucocorticoid
response elements were deleted, including or not the NF-I binding site. Their structure
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Figure 4. SI nuclease protection assay of cytoplasmic RNA from Ltk+ cells stably transfected with LTR-TK
plasmids (as indicated above the lanes).
For quantitative comparisons, aliquots of the S1-digested samples were applied to the gel, corresponding to
the amounts of RNA given above each lane, while the slot-blot at the bottom contains equal amounts (2 jig)
of RNA hybridized to a labeled f,-actin probe. Pools of Ltk+ cells were grown for 16 h in the absence (-)
or presence (+) of IuM dexamethasone in the culture medium before RNA extraction. For S1 analysis, the
(5'-32P)-labeled DNA probe was an LTR fragment from -204 to + 134 with respect to the RNA start site
(0.35-kb Eco RI-Bam HI fragment of the plasmid A47B-ref. 19). Correctly initiated RNA protects from
S1 digestion a fragment of 142 nt. Mutants 201/192 and 196/186 were shown previously to behave similarly
to wild type (18) and are included for comparison. The data for two independent pools of transfectants with
the mutant 90/70 are shown. For double-linker scanning mutants, the RNAs used in lanes 11/12 and 13/14
are those of samples e and h, respectively, of Fig. 5.
and sequence can be deduced from Figure 1, by inserting a Hind HI linker between positions
-193 and -78 (for the mutant that retains the NF-I binding site) or between -193 and
-57 (for the mutant without NF-I binding site). Another pair of plasmids, 193/78E and
193/57E, was derived from the previous ones by inserting the 72-bp repeat enhancer of
SV40 DNA in the Sal I site of the linker upstream of the LTR (Fig. IA), to increase the
overall transcription. Mouse Ltk- cells were transfected with the plasmid DNA and pools
of HAT-resistant clones, selected and grown in the absence of dexamethasone, were
analyzed. Figure 2 (A and B) shows SI nuclease protection assays of cytoplasmic RNA
of cells transfected with the deletion mutants. Correctly initiated RNA protects a fragment
of 142 nucleotides (arrow), from the cap site to the 3' end of the LTR, as indicated in
Figure 1A. The mRNA content of each RNA preparation was verified by slot-blot
hybridization to a mouse (3-actin probe (Fig. lA, bottom) and shown to be constant, within
the limits of experimental variability. Deletion of both glucocorticoid responsive elements
from -193 to -78 resulted, as expected, in the loss of dexamethasone inducibility (Fig.
2B, lanes 4 and 5; and 2A, lanes 7 and 8) but the basal level of transcription was unaffected
when compared to cells stably transfected with the wild-type plasmid (Fig. 2B, lanes 4-5
vs. 1). Additional deletion of the NF-I binding site, in mutant 193/57, resulted in a decrease
of transcription to undetectable levels ( Fig. 2B, lanes 2 and 3; and 2A, lanes 3 and 4).
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Figure 5. SI nuclease protection assay of RNA transcribed from double-linker scanning mutants in stably
transfected cells.
50 Mg of cytoplasmic RNA from independent pools of Ltk+ transfectants (a toj) and 25 Mg of wild-type con-
trol RNA were used. Further details are as in Fig. 4. The panel at the bottom shows a slot-blot analysis with
2 Mg of RNA hybridized to a f-actin probe.
A reduction in the basal level ofmRNA upon deletion of the NF-I binding site was apparent
also in the pair of mutants that contain the SV40 enhancer to augment the overall signal
(Fig. 2A, lanes 5 and 6 compared to lanes 1 and 2). The weaker signal observed with
the same transfectants after treatment with dexamethasone may reflect a toxic effect of
this hormone for L cells (9). A Southern blot analysis of the DNA of the transfectants
is depicted in Figure 1C. It revealed the presence of comparable amounts of integrated
plasmids, as compared to the intensity of the endogenous bands of Ltk- cells (in lane 1).
Moreover, the size of the fragment corresponding to the transfected LTR (between about
1.3 and 1.6 kb) was in accordance with that of the respective plasmids, and no major
rearrangements were detected that could account for the differences in transcription
efficiency of the two mutants.
We had previously observed (18) that Ltk- cells transfected with the mutant 90/70,
where half of the NF-I binding site is deleted, had levels of dexamethasone-induced RNA
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Figure 6. Quantitation of the transcriptional activity of mutant plasmids, based on densitometric scanning of
the 142-nt SI nuclease-protected fragments on autoradiograms. The values, expressed in arbitrary units, are
based on data from 3 to 5 independent pools of stable transfectants (see Fig. 4 and 5). The top line of each
panel depicts the relevant portion ofMMTV LTR with the glucocorticoid response elements defined previous-
ly (Fig. IA). A cross over a box denotes a mutation: for the NF-I element, 90/70 (Fig. IC); for the proximal
element, 125/116 (Fig. 1C); for the distal element, 181/169 (Fig. IB).
five- to ten-fold lower than cells containing the mutant 90/78, in which the NF-I recognition
sequence is intact (Fig. IC). These and other results implied a role for NF-I in glucocorticoid
stimulation of MMTV transcription, in conjunction with hormone-responsive sequence
elements (18,27). We wanted to know if the 90/70 mutation also had an effect on the basal,
uninduced transcription level. First, the in vitro interactions of wild-type and mutant DNA
with NF-I-containing nuclear extracts from Ltk- cells were investigated in DNase I
footprinting experiments (37). As shown in Figure 3, Ltk- cells contain a DNA binding
activity that protected the NF-I recognition sequence (between approximately -80 and
-58; ref.26) of the wild-type DNA, while it did not give any protection, even at the highest
concentration of extract, on the DNA with the 90/70 mutation. In contrast, a footprint
was observed in the same area on the 90/78 mutant DNA. No difference in the patterns
was observed whether the extracts were from untreated or dexamethasone-treated Ltk-
cells. These data suggest that the deletion of half of the NF-I recognition sequence in the
mutant 90/70 strongly reduces its affinity for NF-I in vitro, whereas NF-I binding does
occur when the complete site is preserved, as in the mutant 90/78. Since no further footprints
were observed on these DNAs over the stretch analyzed, it is likely that the NF-I binding
in vitro occurred independently, and that the effect on the base level of transcription observed
3071
Nucleic Acids Research
4,
Figure 7. Spacer insertion mutants.
SI nuclease protection assays were performed with 25 jzg of cytoplasmic RNA of cells transiently transfected
with 20 ytg of MMTV plasmids plus 1 ug of ,B-globin plasmid H5 14. Correctly initiated RNAs protect a frag-
ment of 142 nt of the MMTV probe (as in Fig.2) and of 212 nt of the globin probe (Bam HI-digested pH5 14)
(arrows). When indicated (+), 1 MM dexamethasone was added to the cells 16 h prior to RNA isolation. End-
labeled Hinf I fragments of pBR322 were used as size markers (lane M).
in the mutant 193/78, as opposed to 193/57 (Fig. 2) is due to NF-I binding.
Additional evidence for a functional role of NF-I in the uninduced activity of the MMTV
promoter was obtained in quantitative S 1 nuclease protection assays with RNA from cells
stably transfected with plasmids containing the 90/70 mutation. With respect to wild type,
a reduction in the order of 3- to 5-fold of the level of specific transcripts in the absence
of dexamethasone was observed with the mutant 90/70, either alone (in three independent
pools of transfectants) or in combination with other mutations (see below). A representative
set of data is shown in Figure 4: whenever the 90/70 deletion was present in the transfected
plasmid, the specific band protected by 40 ,ug of RNA (lanes 7,9,11,13) was weaker than
the band protected by only 20 tg of RNA of transfectants with a wild-type phenotype
(lanes 1,3,5). Correction for the mRNA content of the different preparations, as detected
with the 3-actin probe (Fig. 4, bottom) did not alter the conclusions. As a control, the
stimulation factors by dexamethasone were also determined, by comparing with the
SI-protected signals obtained with 100-fold less RNA from hormone-induced cells (Fig.
4, + DEX lanes). In agreement with our previous results (18), the linker-scanning mutants
201/192 and 196/186 (Fig. LB) had an induction factor similar to the wild-type plasmid,
here of approximately 500-fold. For the 90/70 mutant, an induction factor of about 300-fold
was measured, while the absolute level of induced RNA was several fold less than the
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Table 1. Effect of spacer insertions on the relative amounts of dexamethasone induced mRNA
pLS pLS ins spacer ratio
stablea/transientb stablea/transientb + spacer
- spacer
wild type 100/100
-201/- 192 100/180 100/120 1.0
-151/-145 100/n.d. 11/30 0.1-0.3
-90/-78 90/n.d. n.d./15 0.16
-66/-57 40/n.d. 3/4 0.1
a Induced mRNA levels are given as a percentage of wild type
b MMTV signals from induced cells were normalized to the 13-globin signals and expressed as percentage
of wild type (included in the same experiment)
n.d. Not determined
wild type (Fig. 6), in agreement with previous observations (18). We conclude that the
contribution of the NF-I binding site to the glucocorticoid-stimulated MMTV transcription
involves a component that affects the basal promoter activity.
Functional cooperation of NF-I- and proximal glucocorticoid receptor binding sites.
In a previous study using linker-scanning mutants (18) we had identified two glucocorticoid
regulatory elements that mapped in regions of the MMTV DNA that bind hormone/receptor
complexes in vitro (20,2 1). Mutations in the distal element (between -172 and - 181)
reduced the hormone response by ten-to twenty-fold, while a 4-bp mutation in the proximal
element (between -121 and -117) reduced it by approximately five-fold. To investigate
possible functional interactions between either of these elements and the NF-I-binding site,
two double mutants were constructed by recombining single mutants in vitro at a Sst I
restriction site located at position -106 from the RNA start site (Fig. lA). Their structure
can be deduced from Figure 1 B and C: Mutant 181/169//90/70 is simultaneously altered
in the distal and the NF-I regulatory elements, and mutant 125/116//90/70 is simultaneously
altered in the proximal and the NF-I elements. Their transcriptional activity was determined
in stable transfection assays. Five independent pools of Ltk+ cell clones were analyzed
for each mutant. Figures 4 (lanes 11 to 14) and 5 show autoradiograms of SI nuclease
protection assays, along with control 3-actin hybridization below each lane. It is immediately
apparent that the mutant 181/169//90/70 responds only weakly to dexamethasone, while
the mutant 125/116//90/70 shows a more substantial response. This was quantitated more
accurately in titration experiments where dilutions of (+) samples were applied to the gel
next to the undiluted (-) samples, and densitometric values of the 142-nt protected band
were plotted as a function of RNA amount. The quantitative results are summarized in
Figure 6, along with those of identical analyses on the parental single mutants. As shown
in the top panel of Figure 6, removal of the NF-I binding site from an LTR already mutated
in the proximal glucocorticoid responsive element caused a reduction in hormonal
stimulation, with respect to the proximal site single mutant, by approximately the same
factor as for the basal level of transcription (from 500 to 180, while the base level dropped
from 5 to 2). On the other hand (Fig. 6, lower panel), cumulating the NF-I mutation with
a distal-element mutation resulted in a much lower hormonal stimulation than expected
from the drop observed in the basal level: Instead of about 6-fold (from 5 to 0.8 in base
level), the induced level was reduced by almost 60-fold (from 200 to 3.6). These results
show that the distal element alone, in the double mutant 125/116//90/70, was able to provide
a dexamethasone induction in the order of 100-fold, whereas the proximal element alone,
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in the double mutant 181/169//90/70, mediated only a very weak stimulation by
dexamethasone (of about 4-fold over base level). This unexpected weakness of the element
located around position - 120 suggests a requirement for a functional cooperation, in the
natural context of the MMTV regulatory region, between this site and sequences between
-90 and -70, possibly the NF-I binding site.
Construction and analysis of spacer mutants.
The results of the mutational analyses suggested a functional cooperation between the
different regulatory sequences to produce a maximal transcriptional stimulation by
glucocorticoid hormones (18,19, and this study). In an attempt to disrupt such cooperation,
spacer mutants were constructed by inserting a long stretch of DNA between any of the
regulatory elements defined earlier. As a spacer we used a 123-bp Hind III fragment
randomly cloned from mouse DNA for a previous study (19), that does not contain any
transcriptional signals, nor consensus GRE sequences (19). It was chosen in a size range
that should not produce any effects of stereospecificity in the alignment of the regulatory
elements involved (39), but the precise number of base pairs is irrelevant. Via its Hind
HI ends, it was inserted into the DNA of four different linker scanning mutants (18). The
approximate location of the spacer insertions with respect to the regulatory elements in
the MMTV DNA can be deduced from the scheme in Figure 1A. The mutant 201/192
INS contained the spacer sequence upstream of the glucocorticoid regulatory region and
was designed to determine whether the spacer had an inhibitory effect on transcription.
The spacer DNA was inserted between the distal and the proximal receptor binding sites
in the plasmid 151/145 INS, between the proximal element and the NF-I binding site in
90/78 INS, and between the NF-I binding site and the TATA box in 66/57 INS. In the
latter mutant, the palindromic sequence of the NF-I binding site was reconstituted by the
Hind III linker sequence and only the bases at positions -58, -60 and -61 are mutated
(Fig. IC). The transcriptional activity of the spacer mutants was determined in transfection
assays by quantitative SI nuclease mapping. Figure 7 shows the autoradiogram of a transient
expression assay where the MMTV mutants were cotransfected with a plasmid expressing
the genomic rabbit f3-globin gene as an internal standard not affected by dexamethasone.
Globin-specific mRNA protected a 212-nt fragment of a probe 5'-end-labeled at a Bam
HI site in the second exon (40). MMTV-specific transcripts protected a 142-nt fragment.
It can be seen from Figure 7 that their relative abundance in dexamethasone-treated cells
was strongly reduced, compared to wild type, with the spacer insertion mutants 66/57
INS, 90/78 INS, and 151/145 INS, but not with 201/192 INS. Quantitative data from
transient and stable transfection assays are given in Table 1, where the spacer insertion
derivatives are compared with the correspondent linker scanning mutants. Insertion of the
spacer DNA at any of the three positions between regulatory elements decreased the
glucocorticoid response 5 to 10-fold. No decrease was observed when the spacer was
inserted immediately upstream of the GRE at -192, indicating that the inserted sequence
did not exert any inhibitory effect on the promoter.
DISCUSSION
The naturally occurring binding site for NF-I upstream of the MMTV promoter (26,41)
had been previously shown to participate in the MMTV transcriptional stimulation by
glucocorticoid hormones (18,27). Here we show that its function is a dual one: on one
hand as an upstream element for the basal, hormone-independent promoter activity, on
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the other hand as an adjuvant in the hormone response via a synergistic interaction with
the proximal glucocorticoid control element.
Several lines of evidence demonstrate the existence of a basal transcriptional activity
of the MMTV promoter: 5'-deletions of the whole LTR to -105 (8) or -80 (9), and
internal deletions of all glucocorticoid-responsive sequences in an otherwise complete LTR
(- 193/78; Fig. 2B) allowed to experimentally dissociate hormonally stimulated from basal
transcriptional activity. This residual RNA synthesis in stably transfected cells occurs at
the same level as from a wild-type LTR in the absence of glucocorticoids (8,9; Fig. 2B)
and can be detected in SI nuclease protection assays, which allow to discriminate between
correctly initiated and 'read-through' transcripts. It is this basal level of RNA synthesis
that was decreased when the binding of NF-I was prevented (Fig. 3) by removal of the
whole dyad-symmetrical site to -57 (Fig. 2) or of the 5' half of it to -70 (Figs. 4 and
5). We can not exclude a partial contribution of one half-site to the basic promoter activity,
since the deletion 193/57 (both with and without an SV40 enhancer; Fig. 2A) seems to
give a stronger reduction than deletions to only -70 (90/70: Fig. 6; 193/70: ref. 18). The
NF-I binding site can not be replaced by the distal glucocorticoid regulatory element, since
no correct RNA was produced from the mutant 161/57 (19).
It has been reported (42) that NF-I proteins, which constitute a heterogeneous family
with molecular weights between 52 and 66 kd, are biochemically and functionally
indistinguishable from a transcriptional activator (CTF) that recognizes the sequence
CCAAT present in some promoters, e.g. those of the herpes virus TK (43,44), of the
heat-shock hsp70 (45) or of the globin genes (46,47,48,49). Recently, a molecular analysis
of human CTF/NF-I complementary DNA clones (50) pointed to differential splicing as
a source of heterogeneity among members of the family. Still, all individual gene products
analyzed possessed both functions, of transcriptional activators and of initiation factors
for DNA replication (50). A sequence resembling the CCAA(T) consensus AGCCAA (42)
is present in each half of the MMTV NF-I binding site. In vitro, binding affinities are
influenced by the extent of homology to the consensus sequence and by the presence or
absence of a dyad symmetry, while for in vivo function, the position of the CCAAT site
relative to a promoter is also determinant (42). In the case of MMTV, the complete
symmetrical site is clearly required for the participation in glucocorticoid stimulation, since
the half site of the mutant 90/70 was unable to provide a cooperation in Ltk- cells (Fig.
6). In vitro, this mutant was also unable to bind NF-I from Ltk- nuclear extracts (Fig.
3). In human mammary MCF-7 cells as well, glucocorticoid stimulation was destroyed
by the mere alteration of the distance betweeen the two halves (27). Such sensitivity may
reflect a low affinity of the factor for the MMTV site, which shows a rather poor homology
to the consensus sequence (42), as well as different abundances of the factor(s) according
to cell types (50).
From a previous mutational analysis (18) we had deduced that distal and proximal regions
act cooperatively in the glucocorticoid response. The results with spacer- and double-linker
insertion mutants allowed to define in more detail the functional relationships between
elements. At every position where a long DNA segment was inserted to increase the spacing
between elements, the glucocorticoid response dropped approximately ten-fold, to levels
comparable to, or higher than those described for genes where the GREs are located distantly
from the promoter, like the tryptophan oxygenase (TO) gene (51) or the tyrosine
aminotransferase (TAT) gene (52). In TAT, cooperativity between two GREs has been
observed (52). That the high induction factor ofMMTV is the combined result of multiple,
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mutually enhancing elements is apparent from the analysis of double mutants, as compared
to single-site mutants (Fig. 6). We had previously shown that the two short receptor binding
sites between -100 and -78 (20) did not contribute to the glucocorticoid response in
Ltk- cells (53) and therefore the mutant 90/70 is functionally altered in the NF-I binding
site, as reflected in its in vitro binding behaviour (Fig. 3). The distal element, which is
functionally the strongest one (18,19,54) displayed cooperativity with the proximal element,
not with the NF-I site (Fig. 6, Top). The proximal element, by itself exceedingly weak,
displayed a strong cooperativity with the NF-I site (Fig. 6, Bottom). In turn, because of
its effect on the basal level of transcription discussed above, the NF-I site may be considered
as having an interaction with the promoter itself, or with the NF-lI consensus site (55,56)
located 5' of the TATA box, and whose function needs to be elucidated. An enhancement
of the effect of a GRE by the juxtaposition of another element (in this case, the CACCC
box; 49) was observed in the TO gene, both at its natural location at -450 (51) and when
placed closely upstream of the TK promoter in heterologous constructs (57). In intact cells,
an altered reactivity to dimethylsulfoxide following glucocorticoid induction was observed
at a TGT sequence close to the GREs at -2.5 kb of the TAT gene (58). In vitro, no
cooperative binding of the purified glucocorticoid receptor to the MMTV DNA could be
demonstrated (22), nor of NF-I and receptors (26,27). That the NF-I binding site ofMMTV
DNA, in addition to the promoter/cap site region, is involved in transcriptional activity
within the cell was suggested by results of in vivo exonuclease Ill footprinting, where
boundaries of protection were observed at -82 and + 12 in glucocorticoid-treated cells
(41). The fact that no -82 (NF-I) boundary was observed in the absence of dexamethasone
(41) probably reflects the inability of exo 11 to be arrested by factors interacting only
wealdy with the DNA. In fact, in this study (41) no hormone-receptor complexes bound
at the GRE in hormone-treated cells were detected, either. Taken together, these
observations suggest that the hormone-receptor complex might stabilize the interactions
of NF-I and other transcription factors (e.g. TATA-box binding factors, NF-III) with the
promoter. This may occur by cooperative binding, as it was shown for the purified factors
TF-IID and USF on the adenovirus major late promoter (59), or more indirectly by
displacing or altering the interactions with a nucleosome (60). The use of nuclear extracts
for in vitro footprinting experiments and of more sensitive assays in vivo may help clarify
this point. Support for the notion of cooperativity between GRE-bound receptor and
downstream DNA-bound factors may be found in a report (61) showing that the insertion
at -104 of a yeast regulatory element recognized by the GAL4 protein inhibits
glucocorticoid induction in vivo, unless the GAL4 protein is present. Whether the synergistic
effects require direct protein - protein contacts, and whether any of the domains of the
glucocorticoid receptor (in particular the 'modulatory' N-terminal half of it-62,63) are
involved, will need further studies, e.g. using mutated receptor molecules in combination
with wild-type and altered recognition sequences.
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